Topic: drug manufacturing
Astellas plots 600 job cuts in Japan; GSK's infectious disease lead launches a Chinese biotech; Sun Pharma's Zytiga rival wins the FDA's blessing.
Gilead has opened its new $11 million manufacturing facility control lab in Ireland.
South Korea's PRP has acquires a 6,000 meter plant that can produce 2 million vials of the generic ingredient used in wrinkle fighter Botox.
Aspen Pharmacare is expanding into complex meds for cancer and other conditions and has opened an $80 million facility that can produce them.
Indian drugmaker Indoco Remedies was cited by U.K. drug regulators for a number of issues at its manufacturing facility in Goa.
GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.
Takeda weighs a $52 billion Shire bid, WuXi gets approval for a $900M-plus Shanghai IPO, Aslan aims to raise $86 million through an IPO on Nasdaq.
Here's some other vaccine news of note for the week.
China FDA will take a new form; Celltrion's manufacturing issues might be worse than Teva hoped; Wuxi NextCODE and Google Cloud partner up.